These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27926519)

  • 1. Diagnostic and prognostic value of miR-106a in colorectal cancer.
    Hao H; Liu L; Zhang D; Wang C; Xia G; Zhong F; Hu X
    Oncotarget; 2017 Jan; 8(3):5038-5047. PubMed ID: 27926519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis.
    Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
    Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
    EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
    Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
    Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
    Ye H; Hao H; Wang J; Chen R; Huang Z
    Onco Targets Ther; 2017; 10():3685-3696. PubMed ID: 28769572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
    Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
    Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
    Li C; He X; Zhang L; Li L; Zhao W
    BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
    Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
    Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
    J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Value of miR-451 Expression in Colorectal Cancer: A Meta-Analysis.
    Amiri-Dashatan N; Koushki M; Ahmadi NA; Ahmadi H; Rezaei Tavirani M
    Asian Pac J Cancer Prev; 2024 Jun; 25(6):1903-1910. PubMed ID: 38918650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
    Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis.
    Wang Y; Zeng TT
    Genet Mol Res; 2014 Feb; 13(3):7102-12. PubMed ID: 24634297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer.
    Xu J; Ye Y; Zhang H; Szmitkowski M; Mäkinen MJ; Li P; Xia D; Yang J; Wu Y; Wu H
    Medicine (Baltimore); 2016 Jan; 95(2):e2502. PubMed ID: 26765465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer.
    Peng Q; Shen Y; Zhao P; Cheng M; Zhu Y; Xu B
    BMC Cancer; 2020 Jun; 20(1):506. PubMed ID: 32493303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.